Yan Shiju, Wang Meng, Zhao Jian, Zhang Hongtao, Zhou Chengpei, Jin Lei, Zhang Yinglong, Qiu Xiuchun, Ma Baoan, Fan Qingyu
Department of Orthopedics, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China.
Int J Mol Med. 2016 Jul;38(1):201-9. doi: 10.3892/ijmm.2016.2618. Epub 2016 May 31.
Osteoarthritis (OA) is the most prevalent degenerative joint disease with multifactorial etiology caused by risk factors such as ageing, obesity and trauma. Previously, it was reported that the inhibition of microRNA-34a (miR-34a) may reduce rat chondrocyte apoptosis induced by IL-1β, whereas the molecular mechanism and the role of miR-34a in human chondrocyte as well as in OA progression remains to be determined. In the current study, using MTT, luciferase reporter assays and western blot analysis we identified that miR-34a was upregulated while silent information regulator 1 (SIRT1) was inhibited in chondrocytes from 12 OA patients compared with healthy chondrocytes from 10 trauma amputees. Overexpression of miR-34a promoted apoptosis and inhibited cell proliferation in human chondrocytes. Transfection with miR-34a mimic inhibited SIRT1 expression, which attenuated the deacetylation of p53, leading to the upregulation of Bax and downregulation of Bcl-2. Furthermore, results from the western blot analysis and luciferase reporter assay demonstrated that SIRT1 was directly regulated by miR-34a in human chondrocytes. A rat model of OA was induced through anterior cruciate ligament transection and medial meniscus resection (ACLT+MMx). The results showed that the intra‑articular injection of lentiviral vector encoding anti-miR‑34a sequence effectively ameliorated the progression of OA. The results suggest that miR-34a has a crucial role in the pathogenesis of OA through direct regulation of the SIRT1/p53 signaling pathway and serves as a potential therapeutic target of OA.
骨关节炎(OA)是最常见的退行性关节疾病,其病因多因素,由衰老、肥胖和创伤等风险因素引起。此前有报道称,抑制微小RNA-34a(miR-34a)可能减少白细胞介素-1β诱导的大鼠软骨细胞凋亡,而miR-34a在人软骨细胞以及OA进展中的分子机制和作用仍有待确定。在本研究中,我们使用MTT、荧光素酶报告基因检测和蛋白质印迹分析发现,与10名创伤截肢者的健康软骨细胞相比,12名OA患者的软骨细胞中miR-34a上调而沉默信息调节因子1(SIRT1)受到抑制。miR-34a的过表达促进了人软骨细胞的凋亡并抑制了细胞增殖。用miR-34a模拟物转染抑制了SIRT1的表达,这减弱了p53的去乙酰化,导致Bax上调和Bcl-2下调。此外,蛋白质印迹分析和荧光素酶报告基因检测结果表明,在人软骨细胞中SIRT1直接受miR-34a调控。通过前交叉韧带横断和内侧半月板切除术(ACLT+MMx)诱导建立OA大鼠模型。结果表明,关节腔内注射编码抗miR-34a序列的慢病毒载体可有效改善OA的进展。这些结果表明,miR-34a通过直接调控SIRT1/p53信号通路在OA发病机制中起关键作用,并可作为OA的潜在治疗靶点。